Pelabresib (CPI-0610)

Ask supplier a question | View on supplier's website

Pelabresib (CPI-0610) is a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor with an IC50 of 39 nM for BRD4-BD1 in TR-FRET assay and currently undergoing human clinical trials for hematological malignancies. CPI-0610 inhibits the expression of Nuclear receptor binding SET domain protein 3 (NSD3) target genes.

Supplier	Selleck Chemicals
Product #	S7853
Sku #	S7853-5mg
Pricing	5mg, $299.00

Feedback